The Label-Free Detection and Identification of SARS-CoV-2 Using Surface-Enhanced Raman Spectroscopy and Principal Component Analysis

Author:

Zhou Lu12,Vestri Ambra1ORCID,Marchesano Valentina1,Rippa Massimo1ORCID,Sagnelli Domenico1,Picazio Gerardo3ORCID,Fusco Giovanna3ORCID,Han Jiaguang2,Zhou Jun4,Petti Lucia1

Affiliation:

1. Institute of Applied Sciences and Intelligent Systems of CNR, 80072 Pozzuoli, Italy

2. Center for Terahertz Waves and College of Precision Instrument and Optoelectronics Engineering, Tianjin University, Tianjin 300072, China

3. Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Portici, Italy

4. Department of Microelectronic Science and Engineering, School of Physical Science and Technology, Ningbo University, Ningbo 315211, China

Abstract

The World Health Organization (WHO) declared in a May 2023 announcement that the COVID-19 illness is no longer categorized as a Public Health Emergency of International Concern (PHEIC); nevertheless, it is still considered an actual threat to world health, social welfare and economic stability. Consequently, the development of a convenient, reliable and affordable approach for detecting and identifying SARS-CoV-2 and its emerging new variants is crucial. The fingerprint and signal amplification characteristics of surface-enhanced Raman spectroscopy (SERS) could serve as an assay scheme for SARS-CoV-2. Here, we report a machine learning-based label-free SERS technique for the rapid and accurate detection and identification of SARS-CoV-2. The SERS spectra collected from samples of four types of coronaviruses on gold nanoparticles film, fabricated using a Langmuir–Blodgett self-assembly, can provide more spectroscopic signatures of the viruses and exhibit low limits of detection (<100 TCID50/mL or even <10 TCID50/mL). Furthermore, the key Raman bands of the SERS spectra were systematically captured by principal component analysis (PCA), which effectively distinguished SARS-CoV-2 and its variant from other coronaviruses. These results demonstrate that the combined use of SERS technology and PCA analysis has great potential for the rapid analysis and discrimination of multiple viruses and even newly emerging viruses without the need for a virus-specific probe.

Publisher

MDPI AG

Subject

Clinical Biochemistry,General Medicine,Analytical Chemistry,Biotechnology,Instrumentation,Biomedical Engineering,Engineering (miscellaneous)

Reference66 articles.

1. Barai, M.K., and Dhar, S. (2021). COVID-19 Pandemic: Inflicted Costs and Some Emerging Global Issues. Glob. Bus. Rev., 097215092199149.

2. Psychosocial Impact of COVID-19;Dubey;Diabetes Metab. Syndr. Clin. Res. Rev.,2020

3. Bansal, R., Malyadri, P., Singh, A., and Pervez, A. (2021). Advances in Marketing, Customer Relationship Management, and E-Services, IGI Global.

4. World Health Organization (WHO) (2020). Novel Coronavirus (2019-nCoV): Situation Report—11, WHO.

5. World Health Organization (WHO) (2020). Coronavirus Disease 2019 (COVID-19): Situation Report—51, WHO.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3